Yazar "Yilmaz, Seda" seçeneğine göre listele

Listeleniyor 1 - 5 / 5
  • Küçük Resim Yok
    Öğe
    Chronic Myeloid Leukemia After Chemoradiotherapy in a Patient with Non-Small Cell Lung Cancer
    (Akad Doktorlar Yayinevi, 2017) Demircioglu, Sinan; Korkmaz, Levent; Yilmaz, Seda; Bektas, Ozlen; Ceneli, Ozcan; Artac, Mehmet
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    Outcome of Thrombotic Thrombocytopenic Purpura Patients: A Single-Center Experience
    (Galenos Yayincilik, 2019) Ceneli, Ozcan; Yilmaz, Seda; Karaselek, Mehmet Ali; Camli, Kazim
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    Prostate Involvement in a Patient with Follicular Lymphoma
    (Galenos Yayincilik, 2017) Yilmaz, Seda; Demircioglu, Sinan; Bektas, Ozlen; Ceneli, Ozcan; Findik, Sidika
    [Abstract Not Availabe]
  • Küçük Resim Yok
    Öğe
    Thrombotic Thrombocytopenic Purpura in a Patient with Klinefelter Syndrome
    (Aves, 2018) Demircioglu, Sinan; Yilmaz, Seda; Bektas, Ozlen; Ceneli, Ozcan
    Thrombotic thrombocytopenic purpura is a rare disease associated with microangiopathic hemolytic anemia, thrombocytopenia, fever, neurological disorders, and renal insufficiency pentad. It is a fatal hematologic emergency if left untreated. If plasma exchange is feasible, treatment is easy and comfortable. It should be kept in mind that such as in our patient may be acquired at all congenital illnesses.
  • Küçük Resim Yok
    Öğe
    Utility of Different Scoring Systems for the Diagnosis of Thrombotic Microangiopathies
    (Coll Physicians & Surgeons Pakistan, 2023) Yilmaz, Seda; CenelI, Ozcan; Tekinalp, Atakan
    Objective: To investigate the appropriateness of Bentley and plasmic scores and ADAMTS-13 activity to distinguish between primary thrombotic microangiopathies (TMA) syndromes and other thrombotic microangiopathies, as well as primary thrombotic microangiopathies (TTP, complement-related TMA, etc).Study Design: Descriptive study.Place and Duration of the Study: Department of Hematology, Faculty of Medicine, from February 2013 to February 2020.Methodology: Data of patients with non-immune hemolytic anaemia (MAHA) and thrombocytopenia who had ADAMTS-13 test, were analysed. Clinical and laboratory findings, Bentley and plasmic scores, and ADAMTS activity levels were compared.Results: The patients were grouped as primary (n = 27) and secondary (n = 28) TMA, the age was median 38.0 (18-63) years in the primary TMA group and 49.5 (20-84) years in the secondary TMA group. Neurological findings were less in the secondary TMA group (p = 0.008). Plasmic score, lactate dehydrogenase, and total and indirect bilirubin levels were high and D-dimer levels were low in the primary TMA group. In the primary TMA group, a greater number of patients with high plasmic scores were found, whereas all patients in the secondary TMA group had low risk according to Bentley score. Calcium levels were high and platelet levels were low in those with ADAMTS activity level <10% (p = 0.006). The evaluation of primary TMAs demonstrated significant differences in platelet, urea, creatinine, and sodium values between the two groups.Conclusion: Laboratory data and clinical scores are valuable in differentiating primary and other TMA.